What underlies the benefit of famotidine formulations used during COVID-19?
Gastroenterology
.
2020 Aug 7;S0016-5085(20)35020-4.
doi: 10.1053/j.gastro.2020.07.051.
Online ahead of print.
Authors
Vijay P Singh
1
,
Bara El-Kurdi
2
,
Christopher Rood
3
Affiliations
1
Department of Medicine, Mayo Clinic, Scottsdale, AZ. Electronic address: singh.vijay@mayo.edu.
2
University of Texas South Western, Dallas, TX.
3
Saint Louis University School of Medicine, Saint Louis, MO.
PMID:
32777281
PMCID:
PMC7411504
DOI:
10.1053/j.gastro.2020.07.051
No abstract available
Keywords:
COVID-19; Famotidine; Pepcid; calcium.
Publication types
Letter